Amarin Corp Plc (AMRN)

[Nukemtiltheyglow]

Bio: All good stuff; problem is credibility. Looks like Amarin funded the study, hence they put out the PR. Until the market accepts V for what it is (a dam good drug), then this is like a pimple on a you know what. We do need more of these, but 14 patients? I'm banking on Reduce-it to kick butt.... Since the DMC can stop a study at 30% efficacy? Why not wait, unless this is a pre-emptive strike for the Kowa Reps hitting the streets.